• SB203580 Workflows for p38 MAPK Research

  2026-08-27

  Use SB203580 as a pathway-perturbation tool to separate p38 MAPK signaling from upstream activation, downstream transcription, and regenerative function. This practical guide adapts findings from diabetic bladder dysfunction research into cell-based workflows, controls, dosing logic, and troubleshooting strategies.

• GSK621: AMPK Agonist for AML Metabolism

  2026-08-27

  GSK621 enables controlled AMPK pathway activation across acute myeloid leukemia, metabolic, and tumor-macrophage assays. This guide combines practical handling, phospho-signaling workflows, apoptosis and autophagy readouts, and a mechanistic bridge to 25-hydroxycholesterol biology.

• Transmembrane Protein Degradation by ERAD

  2026-08-26

  Song et al. introduce ERAD-engaging chimeras (ERADECs), a small-molecule strategy that redirects the endoplasmic reticulum-associated degradation pathway toward transmembrane proteins. By using desonide to engage the ER E3 ligase SYVN1, the study achieves potent PD-L1 degradation and demonstrates a broader route for targeted protein degradation beyond lysosome-dependent systems.

• Quercetin and Ferroptosis in Wilson’s Disease

  2026-08-26

  A 2026 Phytomedicine study shows that Quercetin reduces hepatic injury in Wilson’s disease models by suppressing ferroptosis through the ACSL4/LPCAT3/ALOX15 axis. Its integrated use of lipidomics, biochemical assays, ultrastructural analysis, and target-engagement experiments provides a mechanistic framework for studying metal-overload liver injury, while remaining preclinical.

• H-89 and Bone Anabolism: Testing the PKA–Wnt Axis

  2026-08-25

  H-89 provides a practical pharmacological entry point for testing how cAMP-dependent protein kinase activity connects Wnt signaling with O-GlcNAcylation, glycolysis, and osteoblastogenesis. This article translates recent bone biology into an experimentally disciplined strategy for pathway validation and translational decision-making.

• Hydrocortisone: From Receptor Assay to Delivery Design

  2026-08-25

  Hydrocortisone is more than a glucocorticoid hormone reference: it can connect receptor biology with controlled-delivery engineering. This article translates recent PLGA microsphere findings into practical decisions for inflammation, barrier, stress-response, and cartilage studies.

• Neuroligin 1, PKC, and Repetitive Behavior

  2026-08-24

  The reference study identifies a cell-type-specific mechanism linking Neuroligin 1 loss in striatal D2 receptor-expressing medium spiny neurons to autistic-like repetitive behavior. By integrating behavioral manipulation, neuronal activity analysis, single-nucleus RNA sequencing, and protein validation, the work implicates excessive PKC signaling and altered D2-MSN excitability as mechanistic contributors.

• Auranofin at the Cytoskeleton–Redox Interface

  2026-08-24

  A mechanistic and translational framework for using Auranofin as a thioredoxin reductase inhibitor, linking oxidative stress modulation and apoptosis induction via caspase activation with emerging evidence that cytoskeletal architecture controls mechanical stress-induced autophagy.

• AZD3463: From Kinase Biology to Translation

  2026-08-23

  A mechanistic and strategic guide to using AZD3463 as an ALK/IGF1R inhibitor in neuroblastoma and ALK-driven cancer research, with emphasis on pathway validation, resistance-oriented model selection, combination studies, and translational evidence boundaries.

• Pomalidomide: A Genotype-Aware Myeloma Guide

  2026-08-22

  Pomalidomide and CC-4047 are powerful tools for hematological malignancy research, but response data should be interpreted through model genetics and assay context. This guide connects pomalidomide biology with mutation-aware multiple myeloma study design, erythroid readouts, and reproducible compound handling.

• In Vitro Drug Response Metrics in Cancer

  2026-08-22

  Hannah Schwartz’s 2022 dissertation shows why relative viability and fractional viability should not be treated as interchangeable measures of anticancer activity. Its central contribution is a framework for separating proliferation arrest from cell death while accounting for their different proportions and timing, improving interpretation of preclinical drug-response experiments.

• Cyclopamine: Reliable Hh Assay Design

  2026-08-21

  Cyclopamine SKU A8340 offers a practical, mechanistically defined approach to interrogating Smoothened-dependent Hedgehog signaling in viability, proliferation, apoptosis, and developmental assays. This scenario-based guide connects formulation, dosing, controls, data interpretation, and supplier-selection decisions to evidence-backed laboratory workflows.

• Sodium Oxamate: From Flux Block to Causal Biology

  2026-08-20

  Sodium Oxamate is more than an LDH-A inhibitor: it can help connect lactate production with chromatin state and cancer-cell fate. This article presents a causal assay framework grounded in recent triple-negative breast cancer research.

• Reelin Signaling Permits Ketamine Synaptic Action

  2026-08-20

  This PNAS study identifies Reelin–Apoer2–Src family kinase signaling as a permissive pathway for ketamine-induced hippocampal synaptic plasticity and behavioral effects in mice. Its central contribution is the distinction between pathway activation by ketamine and maintenance of baseline NMDA receptor function, offering a mechanistic framework for understanding incomplete ketamine responsiveness.

• Blue Light, EGFR/ERK/c-Jun, and Skin Barrier Damage

  2026-08-19

  The reference study establishes a human- and mouse-based framework showing that repeated blue light exposure produces persistent structural, pigmentary, and functional skin-barrier abnormalities. Its mechanistic contribution is the identification of EGFR/ERK/c-Jun signaling as a pathway linking visible-light irradiation to epidermal stress and barrier dysfunction.

8076 records 1/539 page Next 12345 下5页 Last page